文献速递心脑血管急症重症综合管理与镇静镇痛

2020-2022年全国住院患者样本中非创伤性颅内出血患者合并COVID-19感染及其相关结局分析

COVID-19 Infection and Associated Outcomes in Patients with Nontraumatic Intracerebral Hemorrhage: Analysis of National Inpatient Sample 2020-2022.
PubMed 文献 · Neurocrit Care · 2025-04-14
一句话结论合并COVID-19使非创伤性颅内出血患者院内死亡风险约为无COVID-19者的2.4倍(aOR 2.432),全身并发症、住院时间与费用也更高。

该研究基于2020至2022年全国住院患者样本数据库,纳入99,780例非创伤性颅内出血患者,其中4917例(4.9%)合并COVID-19感染。多因素logistic回归校正人口学、基础合并症与出血严重程度后,COVID-19感染与更高的院内死亡(aOR 2.432;95%CI 2.273-2.602)、全身并发症(aOR 1.527;95%CI 1.432-1.628)、更长住院时间(aOR 2.115;95%CI 1.957-2.286)及更高住院费用(aOR 1.256;95%CI 1.162-1.357)独立相关。相反,COVID-19感染与更低的神经系统并发症风险相关(aOR 0.811;95%CI 0.76-0.865)。作者认为COVID-19加剧了颅内出血患者中年轻、社会经济弱势及少数族群人群的既有差异。

要点

  • 合并COVID-19的颅内出血患者院内死亡风险显著升高(aOR 2.432;95%CI 2.273-2.602)。
  • 合并COVID-19者全身并发症风险更高(aOR 1.527;95%CI 1.432-1.628),住院时间更长(aOR 2.115;95%CI 1.957-2.286)。
  • 合并COVID-19者住院费用更高(aOR 1.256;95%CI 1.162-1.357)。
  • 合并COVID-19者神经系统并发症风险反而更低(aOR 0.811;95%CI 0.76-0.865)。
  • COVID-19阳性颅内出血患者更年轻(中位66岁 vs 68岁),更多为黑人(25.6% vs 23.5%)或西班牙裔(17.1% vs 10.9%),更多处于家庭收入最低四分位(31.4% vs 29.2%)。

适用人群与场景

  • 2020至2022年全国住院患者样本中诊断为非创伤性颅内出血的住院患者,比较合并与不合并COVID-19感染者。

研究设计与关键结果

  • 研究类型为基于全国住院患者样本数据库的分析,共纳入99,780例颅内出血患者,其中4917例(4.9%)合并COVID-19感染。
  • COVID-19阳性组较阴性组更年轻(中位66岁[IQR 55-76] vs 68岁[IQR 57-78]),黑人比例更高(25.6% vs 23.5%),西班牙裔比例更高(17.1% vs 10.9%),家庭收入最低四分位比例更高(31.4% vs 29.2%),各项P<0.05。
  • 校正人口学、基础合并症与颅内出血严重程度后,COVID-19感染与院内死亡风险升高独立相关(aOR 2.432;95%CI 2.273-2.602)。
  • COVID-19感染与全身并发症风险升高(aOR 1.527;95%CI 1.432-1.628)、住院时间延长(aOR 2.115;95%CI 1.957-2.286)及住院费用升高(aOR 1.256;95%CI 1.162-1.357)独立相关。
  • COVID-19感染与神经系统并发症风险降低相关(aOR 0.811;95%CI 0.76-0.865)。

证据类型、等级与局限

  • 证据类型为基于全国住院患者样本数据库的分析;P<0.05为统计学显著。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,合并COVID-19的颅内出血患者临床结局更差、医疗资源使用更多,应关注大流行对急性神经系统疾病患者尤其是弱势人群的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Nontraumatic intracerebral hemorrhage (ICH) is a devastating form of stroke with high mortality and morbidity. The COVID-19 pandemic introduced additional complexities and challenges in managing ICH. This study evaluates the impact of concurrent COVID-19 infection on the demographics, outcomes, and resource use of patients with ICH. The primary outcome was in-hospital mortality, and secondary outcomes included neurological and systemic complications, length of stay, and cost of hospitalization.

METHODS: The National Inpatient Sample database was screened to identify patients with and without COVID-19 infection and ICH from 2020 to 2022. Sociodemographic characteristics, comorbidities, and clinical severity were compared between the two groups. Multivariate logistic regression was used to calculate adjusted odds ratios (aORs) for the preselected outcomes. A p value of < 0.05 was considered statistically significant.

RESULTS: A total of 99,780 patients with ICH were included, of whom 4917 (4.9%) had concomitant COVID-19 infection. COVID-19-positive patients with ICH were younger (median 66 [interquartile range (IQR) 55-76] vs. 68 [IQR 57-78], years), more likely to identify as Black (25.6 vs. 23.5%) or Hispanic (17.1 vs. 10.9%), and more frequently in the lower quartile of median household income (31.4 vs. 29.2%) (p < 0.05 for all). Distinct multivariate regression models adjusted for demographics, baseline comorbidities, and ICH severity revealed that COVID-19 infection was independently associated with higher odds of in-hospital mortality (aOR 2.432; 95% confidence interval [CI] 2.273-2.602), systemic complications (aOR 1.527; 95% CI 1.432-1.628), longer hospital stay (aOR 2.115; 95% CI 1.957-2.286), and higher hospitalization costs (aOR 1.256; 95% CI 1.162-1.357). In contrast, COVID-19 infection was also associated with lower odds of neurological complications (aOR 0.811; 95% CI 0.76-0.865).

CONCLUSIONS: COVID-19 exacerbated the existing disparities in ICH, disproportionately affecting younger, socioeconomically disadvantaged, and minority populations. Additionally, patients with ICH with concomitant COVID-19 infection experienced worse clinical outcomes and greater healthcare resource use. These findings highlight the impact that the pandemic had on patients with acute neurological conditions, particularly among more vulnerable populations.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Loggini A, Saleh Velez FG, Henson J, et al. COVID-19 Infection and Associated Outcomes in Patients with Nontraumatic Intracerebral Hemorrhage: Analysis of National Inpatient Sample 2020-2022. Neurocrit Care. 2025. PMID: 40229633. doi:10.1007/s12028-025-02259-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。